Ra Pharmaceuticals to Present at Upcoming Investor Conferences

Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced that senior management will present at the following upcoming investor conferences:

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Tuesday, May 14, 2019
Information
Tags: 
Health, Biotechnology, Clinical trials, Infectious diseases, Pharmaceutical, Research, Other Science, Science, Life sciences, Articles, Health, Biopharmaceutical, Biotechnology, Pharmaceutical industry, Pharmacy, Pharmaceutical industry in China
Geotags: 
United States, Massachusetts, NEW YORK
⚠generated by AI ↴
Summary
Key Points: 
  • Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced that senior management will present at the following upcoming investor conferences:
    The UBS Global Healthcare Conference 2019 on Tuesday, May 21, 2019 at 9:00 a.m. E.T.
  • The 2019 RBC Capital Markets Global Healthcare Conference on Wednesday, May 22, 2019 at 11:30 a.m. E.T.
  • The presentations will be webcast live and can be accessed by visiting the investor relations section of the Companys website, www.rapharma.com .
  • Ra Pharmaceuticals is a clinical-stage biopharmaceutical company focused on leading the field of complement biology to bring innovative and accessible therapies to patients with rare diseases.


Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced that senior
management will present at the following upcoming investor conferences:

  • The UBS Global Healthcare Conference 2019 on Tuesday, May 21, 2019 at
    9:00 a.m. E.T. The conference will be held at the Grand Hyatt New York
    in New York, NY.
  • The 2019 RBC Capital Markets Global Healthcare Conference on
    Wednesday, May 22, 2019 at 11:30 a.m. E.T. The conference will be held
    at the InterContinental New York Barclay in New York, NY.

The presentations will be webcast live and can be accessed by visiting
the investor relations section of the Company’s website, www.rapharma.com.
A replay of each presentation will be available and archived on the site
for three weeks.

About Ra Pharmaceuticals

Ra Pharmaceuticals is a clinical-stage biopharmaceutical company focused
on leading the field of complement biology to bring innovative and
accessible therapies to patients with rare diseases. The Company
discovers and develops peptides and small molecules to target key
components of the complement cascade. For more information, please
visit: www.rapharma.com.

Copyright: 
Copyright Business Wire 2019